ORL-1B

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
255	複合カルボキシラーゼ欠損症	1

255. 複合カルボキシラーゼ欠損症

臨床試験数 : 1 / 薬物数 : 1 - (DrugBank : 0) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03269045 (ClinicalTrials.gov)	August 31, 2013	28/8/2017	Study of ORL-1B in Patients With Biotinidase Deficiency	An Open-label, Single-arm, Phase 2 Study of ORL-1B in Patients With Biotinidase Deficiency	Biotinidase Deficiency	Drug: ORL-1B	Orpha Labs	NULL	Completed	N/A	18 Years	All	20	Phase 1/Phase 2	NULL